Clinical Trial Update: Combining Lovastatin and a Parent-Implemented Language Intervention for Fragile X Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the combination of Lovastatin with a parent-implemented language intervention for Fragile X Syndrome has completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fragile Syndrome

Drugs mentioned

• Lovastatin (Lovastatin)

Snippet

Sponsor: University of California, Davis | Conditions: Fragile X Syndrome, Genetic Diseases | Phase 4 | Status: COMPLETED | Results posted: 2019-09-11